Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
SolarBank - Solarenergie...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
159 Leser
Artikel bewerten:
(0)

Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend

ST. LOUIS, Oct. 19, 2011 /PRNewswire/ -- Young Innovations, Inc. (NASDAQ: YDNT) today announced record earnings per share for the third quarter and record sales and EPS for the nine-months ended September 30, 2011.

Sales for the third quarter of 2011 were $26.2 million, a decrease of 0.9% from the $26.4 million reported for the third quarter of 2010. Income from operations for the third quarter increased 2.8% to $6.3 million from $6.1 million in the prior year quarter. Net income for the third quarter increased 4.6% to $4.1 million from $3.9 million in the third quarter of 2010. Diluted earnings per share for the third quarter of 2011 were $0.51, an increase of 4.1% over the $0.49 reported in the prior year quarter. Diluted earnings per share were affected by equity compensation expense of $0.04 in both the third quarter of 2011 and 2010. Diluted shares outstanding were 8.0 million for the 2011 quarter, unchanged from the prior year quarter.

For the nine months ended September 30, 2011, sales were $79.5 million, increasing 3.3% from the $77.0 million reported in the prior year period. Income from operations increased 6.1% to $18.2 million for the nine months ended September 30, 2011 from $17.2 million in the prior year period. Net income was $12.1 million for the nine months ended September 30, 2011, increasing 8.6% from $11.2 million in the prior year period. Diluted earnings per share were $1.51 for the nine months ended September 30, 2011, an increase of 8.6% from $1.39 in the prior year period. Diluted earnings per share were affected by equity compensation expense of $0.11 for both the nine months ended September 30, 2011 and 2010. Diluted shares outstanding for the nine months ended September 30, 2011 increased 0.3% to 8.1 million from the prior year period.

During the quarter, demand for consumables was negatively affected by the ongoing weak economy, as well as the timing of orders from OEM and international customers. We continued to experience a solid increase in demand for our diagnostic product line. Despite relatively flat sales performance, we are pleased with the overall strength of our earnings in the quarter. A weaker U.S. dollar positively impacted sales by approximately $136,000.

We remained focused on executing our strategy for growth during the quarter. We enhanced our sales capacity and made significant progress toward future product launches. We also took steps to consolidate a number of administrative and light assembly operations into our Algonquin facility.

We are pleased with the efforts of our employees to make significant improvements in operating results in an uncertain economic environment. We are confident that continued investments in key initiatives and our strong balance sheet have well-positioned the Company for future growth.

The company also announced that on October 18, 2011 the Board of Directors declared a quarterly dividend of $0.04 per share, payable on December 15, 2011 to all shareholders of record on November 15, 2011.

A conference call has been scheduled for Thursday, October 20, 2011 at 11:00 A.M. Central Time and can be accessed through InterCall at http://tinyurl.com/YI-Quarter32011 or the Company's website, www.ydnt.com.

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. In addition, the Company offers a line of diagnostic products that includes panoramic X-ray machines and related supplies. The Company believes it is a leading U.S. manufacturer or distributor of prophy angles and cups, liquid surface disinfectants, dental micro-applicators and obturation units designed for warm, vertical condensation.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995. Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions. These statements are not guarantees of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements. Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Young Innovations, Inc.

Consolidated Statements of Income

(In thousands, except earnings per share data)

(Unaudited)

(In Thousands USD)












Three Months Ended



Nine Months Ended



September 30,



September 30,



2011


2010

Change


2011


2010

Change











Net Sales

$ 26,197


$ 26,423

-0.9%


$ 79,548


$ 76,982

3.3%

Cost of Goods Sold

$ 11,585


$ 11,841

-2.2%


$ 35,325


$ 34,003

3.9%

Gross Profit

$ 14,612


$ 14,582

0.2%


$ 44,223


$ 42,979

2.9%

% of Net Sales

55.8%


55.2%



55.6%


55.8%












Selling, General and Administrative Expense

$ 8,359


$ 8,501

-1.7%


$ 26,000


$ 25,799

0.8%

% of Net Sales

31.9%


32.2%



32.7%


33.5%












Income from Operations

6,253


6,081

2.8%


18,223


17,180

6.1%

% of Net Sales

23.9%


23.0%



22.9%


22.3%












Interest expense, net

(49)


(81)



(177)


(263)


Other income (expense), net

100


(62)



568


86












Income Before Taxes

6,304


5,938

6.2%


18,614


17,003

9.5%











Provision for Income Taxes

2,204


2,019



6,477


5,826












Net Income

$ 4,100


$ 3,919

4.6%


$ 12,137


$ 11,177

8.6%

% of Net Sales

15.7%


14.8%



15.3%


14.5%












Basic Earnings Per Share

$ 0.51


$ 0.49

4.1%


$ 1.51


$ 1.40

7.9%











Basic Weighted Average Shares Outstanding

8,018


7,953



8,013


7,969












Earnings Per Share (Diluted)

$ 0.51


$ 0.49

4.1%


$ 1.51


$ 1.39

8.6%











Diluted Weighted Average Shares Outstanding

8,041


8,013



8,065


8,038




YI Consolidated

Consolidated Balance Sheet

September 30, 2011 and December 31, 2010

(In Thousands USD)




(Unaudited)





September 30


December 31

Assets

2011


2010

Current assets





Cash

$ 4,000


$ 741


Accounts receivable, net

13,340


11,721


Inventories

17,598


17,260


Other current assets

4,805


4,861

Total current assets

39,743


34,583






Property, plant and equipment, net

32,726


33,162

Goodwill

80,300


80,289

Intangible assets

11,260


11,579

Other assets

1,508


2,012






Total assets

$ 165,537


$ 161,625






Liabilities and Equity




Current liabilities





Accounts payable and accrued liabilities

$ 10,236


$ 10,700

Total current liabilities

10,236


10,700






Long-term debt

-


6,100

Long-term secured borrowing

22


56

Deferred income taxes

17,484


17,417

Other noncurrent liabilities

240


248

Total liabilities

27,982


34,521






Stockholders' equity





Common stock

102


102


Additional paid-in capital

24,084


24,190


Retained earnings

162,607


151,458


Common stock in treasury, at cost

(49,090)


(48,484)


Accumulated other comprehensive income

(148)


(162)

Total stockholders' equity

137,555


127,104






Total liabilities and stockholders' equity

$ 165,537


$ 161,625



SOURCE Young Innovations, Inc.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.